Oncolytics Biotech Inc. (ONCY:NASDAQ) jumped higher at $3.6, representing a gain of 17.3%. On Mon 22 Mar 21, ONCY:NASDAQ touched a New 2-Week Intraday High of $3.18. The stock appeared on our News Catalysts scanner on Wed 10 Mar 21 at 06:02 PM in the 'BIOTECH' category. From Mon 08 Mar 21, the stock recorded 80.00% Up Days and 54.55% Green Days
The stock spiked on Wed 17 Feb 21 at $4.7 with a volume of 20M+, and its share price has been moving sideways in recent weeks.
About Oncolytics Biotech Inc. (ONCY:NASDAQ)
Oncolytics Biotech Inc is a development stage biopharmaceutical company. It is engaged in the discovery and development of pharmaceutical products for the treatment of cancer that have not been successfully treated with conventional therapeutics.
Top 10 Gainers:
- Dolphin Entertainment, Inc. (DLPN:NASDAQ), 236.33%
- Benitec Biopharma Inc. (BNTC:NASDAQ), 190.28%
- Sanchez Midstream Partners LP (SNMP:NYSEMKT), 51.43%
- Liquid Media Group Ltd. (YVR:NASDAQ), 22.92%
- Oncolytics Biotech Inc. (ONCY:NASDAQ), 17.26%
- Concord Medical Services Holdings Limited (CCM:NYSE), 16.09%
- CLA (CLA:NYSE), 15.94%
- Hoth Therapeutics, Inc. (HOTH:NASDAQ), 15.14%
- NantKwest, Inc. (NK:NASDAQ), 14.89%
- Glory Star New Media Group Holdings Limited (GSMG:NASDAQ), 14.41%